Wednesday, January 22, 2025

Quantiphi, DDReg Partner to Transform Regulatory Reporting in Life Sciences Through AI

Related stories

Prompt Security Launches Enhanced GitHub Copilot Solution

Prompt Security, a leader in generative AI (GenAI) security,...

Buck.ai & AccuKnox Partner for Zero Trust Security

AccuKnox, a leading provider of Cloud Native Application Protection...

Freename Launches .etherlink Domain for Web3 Identity

Freename, a leading multi-chain Web3 namespace platform, has teamed...

EarnOS raises $5 Million to reinvent brand-user interactions

Embracing Web3, EarnOS delivers global engagements where “everyone wins.”...

Mauna Kea Gains New U.S. AI Patent for Endomicroscopy

Mauna Kea Technologies, inventor of Cellvizio®, the multidisciplinary probe...
spot_imgspot_img

Quantiphi, a global AI-first digital engineering company and DDReg, a global leader in regulatory expertise announced a partnership that will address regulatory challenges that pharmaceutical companies, biotechnology firms, medical device and cosmetics manufacturers face by bringing innovations to market more quickly through AI.

Quantiphi Global Head of Healthcare and Life Sciences Barinder Marhok said the partnership marries DDReg’s expertise in global regulatory process management and securing and renewing government approvals for healthcare interventions with Quantiphi’s expertise in AI-managed processes and documents.

“As the life sciences industry grapples with the ever-evolving regulation landscape, Quantiphi and DDReg have come together to help deliver cutting-edge solutions that streamline regulatory processes across both the drug development and commercialization lifecycle, ultimately helping improve more lives,” Marhok said. “Leveraging cloud, data and AI technologies, our joint efforts aim to accelerate approvals, enhance compliance and optimize Life Cycle Management (LCM), ensuring a faster and more efficient path to market.”

Also Read: Aignostics Raises $34M Series B to Enhance Precision Medicine With AI

DDReg Managing Director Neeti Pant said “Our collaboration harnesses DDReg’s unparalleled regulatory knowledge and Quantiphi’s innovative technology, along with a deep understanding of artificial intelligence to revolutionize regulatory processes. Together, we are transforming how the life sciences sector navigates some of its most pressing regulatory challenges, ensuring compliance, enhancing safety and accelerating the time to market for new therapies. This collaboration will not only address current regulatory demands but also anticipate future needs, providing a framework for sustainable growth and innovation. By combining our strengths, we are paving the way for a more streamlined, effective, proactive and cost-efficient approach to regulatory affairs in the life sciences industry.”

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img